Table 5 Metastasis-free survival analyses for UBEC2C and Ki-67 adjusted for NPI (parametric and 1000-permutation tests)
From: Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
Variable | HR | HR 95% CI | Parametric P -value | 1000-permutation P -value |
|---|---|---|---|---|
NPIa | ||||
1, 2 vs 3 | 3.65 | 1.44–9.24 | 0.006 | 0.002 |
UBE2C IHC | ||||
<11% vs ⩾11% | 3.83 | 1.06–13.81 | 0.041 | 0.024 |
NPI b | ||||
1, 2 vs 3 | 4.30 | 1.68–11.03 | 0.002 | 0.001 |
Ki-67 IHC | ||||
<11% vs ⩾11% | 2.65 | 0.56–12.59 | 0.220 | 0.195 |
